Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Comment by spammeon Apr 09, 2012 3:32pm

152 Views

Post# 19772786

RE: RE: RE: RE: Good News - Excellent Links

I was talking about Gold. Gold has increased 8 folds in the last 11 years.

They are really doing a terrible job manipulating it.

People want to see conspiracy theories as soon as something does not go their way.

BTW BRD's price is where its at because all gold stocks are hated right now and BRD's management has dissappointed investors for 2 years. So they had 1 quarter where they have met their own guidance they will need a few more to prove that this is sustainable. Sentiment will not turn around over night.

If you think it is cheap buy it just stop crying about the bogeymen...

Bullboard Posts

Investors eye Australian gold mining projects amid promising developments